DUOS TECHNOLOGIES GROUP INC (DUOT) Fundamental Analysis & Valuation

NASDAQ:DUOT • US2660424076

Current stock price

8.69 USD
-0.15 (-1.7%)
Last:

This DUOT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DUOT Profitability Analysis

1.1 Basic Checks

  • DUOT had negative earnings in the past year.
  • DUOT had a negative operating cash flow in the past year.
  • In the past 5 years DUOT always reported negative net income.
  • DUOT had a negative operating cash flow in each of the past 5 years.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -15.51%, DUOT is doing worse than 70.22% of the companies in the same industry.
  • DUOT's Return On Equity of -20.26% is on the low side compared to the rest of the industry. DUOT is outperformed by 60.66% of its industry peers.
Industry RankSector Rank
ROA -15.51%
ROE -20.26%
ROIC N/A
ROA(3y)-44.61%
ROA(5y)-49.93%
ROE(3y)-235.26%
ROE(5y)-329.13%
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K

1.3 Margins

  • Looking at the Gross Margin, with a value of 29.15%, DUOT is doing worse than 80.15% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DUOT has grown nicely.
  • DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y57.74%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DUOT Health Analysis

2.1 Basic Checks

  • DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DUOT has been increased compared to 1 year ago.
  • DUOT has more shares outstanding than it did 5 years ago.
  • DUOT has a better debt/assets ratio than last year.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 8.83 indicates that DUOT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.83, DUOT belongs to the top of the industry, outperforming 88.60% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that DUOT is not too dependend on debt financing.
  • The Debt to Equity ratio of DUOT (0.00) is better than 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.83
ROIC/WACCN/A
WACC10.87%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • DUOT has a Current Ratio of 2.08. This indicates that DUOT is financially healthy and has no problem in meeting its short term obligations.
  • DUOT has a Current ratio (2.08) which is in line with its industry peers.
  • DUOT has a Quick Ratio of 2.05. This indicates that DUOT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of DUOT (2.05) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 2.05
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DUOT Growth Analysis

3.1 Past

  • DUOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.71%, which is quite impressive.
  • The Revenue has grown by 271.16% in the past year. This is a very strong growth!
  • Measured over the past years, DUOT shows a very strong growth in Revenue. The Revenue has been growing by 27.44% on average per year.
EPS 1Y (TTM)50.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.41%
Revenue 1Y (TTM)271.16%
Revenue growth 3Y21.65%
Revenue growth 5Y27.44%
Sales Q2Q%523.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y117.74%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year44.93%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. DUOT Valuation Analysis

4.1 Price/Earnings Ratio

  • DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 71.00, DUOT can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as DUOT.
  • When comparing the Price/Forward Earnings ratio of DUOT to the average of the S&P500 Index (22.12), we can say DUOT is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 71
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DUOT Dividend Analysis

5.1 Amount

  • DUOT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DUOT Fundamentals: All Metrics, Ratios and Statistics

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (4/28/2026, 9:39:59 AM)

8.69

-0.15 (-1.7%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-31
Earnings (Next)05-18
Inst Owners25.61%
Inst Owner Change-2.35%
Ins Owners11.03%
Ins Owner Change-2.89%
Market Cap256.70M
Revenue(TTM)27.02M
Net Income(TTM)-9.84M
Analysts82.86
Price Target14.28 (64.33%)
Short Float %6.99%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-659.8%
Min EPS beat(2)-1370.59%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)-338.61%
Min EPS beat(4)-1370.59%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-173.38%
EPS beat(12)5
Avg EPS beat(12)-130.33%
EPS beat(16)8
Avg EPS beat(16)-97.52%
Revenue beat(2)0
Avg Revenue beat(2)-9.17%
Min Revenue beat(2)-10.7%
Max Revenue beat(2)-7.64%
Revenue beat(4)2
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-10.7%
Max Revenue beat(4)13.61%
Revenue beat(8)4
Avg Revenue beat(8)-4.11%
Revenue beat(12)5
Avg Revenue beat(12)-12.44%
Revenue beat(16)7
Avg Revenue beat(16)-7.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)14.29%
Revenue NQ rev (3m)14.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 71
P/S 9.5
P/FCF N/A
P/OCF N/A
P/B 5.29
P/tB 5.32
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)0.12
Fwd EY1.41%
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0.91
BVpS1.64
TBVpS1.63
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -15.51%
ROE -20.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.15%
FCFM N/A
ROA(3y)-44.61%
ROA(5y)-49.93%
ROE(3y)-235.26%
ROE(5y)-329.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y57.74%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1048.81%
Cap/Sales 87.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 2.05
Altman-Z 8.83
F-Score5
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)443.62%
Cap/Depr(5y)342.03%
Cap/Sales(3y)42.59%
Cap/Sales(5y)27.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.41%
EPS Next Y117.74%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)271.16%
Revenue growth 3Y21.65%
Revenue growth 5Y27.44%
Sales Q2Q%523.48%
Revenue Next Year44.93%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-603.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.08%
OCF growth 3YN/A
OCF growth 5YN/A

DUOS TECHNOLOGIES GROUP INC / DUOT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DUOS TECHNOLOGIES GROUP INC?

ChartMill assigns a fundamental rating of 3 / 10 to DUOT.


What is the valuation status of DUOS TECHNOLOGIES GROUP INC (DUOT) stock?

ChartMill assigns a valuation rating of 1 / 10 to DUOS TECHNOLOGIES GROUP INC (DUOT). This can be considered as Overvalued.


What is the profitability of DUOT stock?

DUOS TECHNOLOGIES GROUP INC (DUOT) has a profitability rating of 1 / 10.


How financially healthy is DUOS TECHNOLOGIES GROUP INC?

The financial health rating of DUOS TECHNOLOGIES GROUP INC (DUOT) is 5 / 10.